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Stentless valve dehiscence
To the Editor:
With great interest we read the article by
Richard Hopkins and colleagues1 on their
patient who experienced dehiscence of the
preserved noncoronary sinus after subcoro-
nary allograft replacement of the aortic
valve. The authors write that this complica-
tion might not be unique for this method of
allograft implantation and that it could in
fact occur with any type of inclusion tech-
nique, as long as sinuses are retained. They
also suggest that some methods of insertion
of stentless xenograft valves could also be
liable to this complication.
We can confirm that dehiscence of the
stentless xenograft indeed occurs and that
it has a strong predilection for the noncoro-
nary sinus. In 10 of 168 patients, partial
dehiscence was found 4 to 49 months after
subcoronary implantation of a stentless xe-
nograft with preserved noncoronary sinus.2
In contrast to the reported patient, our pa-
tients all received diagnoses relatively early
and all underwent reoperations for present
or feared valve dysfunction. The mecha-
nism, however, seems similar. Supposedly,
proteolytic enzymes from captured blood
cells in the dead space between native and
donor aortas might prevent adequate fusion
of the walls and healing of the anastomosis.
The assumption that this particular prob-
lem is related to the concept of coronary
sinus inclusion seems very likely, and clo-
sure of the dead space might be important
when this particular technique is used.
Paul H. Schoof, MD, PhD
Department of Cardiothoracic Surgery
University Medical Center St Radboud
Nijmegen, The Netherlands
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Reply to the Editor:
We appreciate Professor Schoof and his col-
leagues for confirming our observations
concerning the technical predilections for
this complication. We use the stentless xe-
nograft as an aortic root replacement, and
therefore we have no experience with tech-
niques liable to this complication, except
historically with homografts. The 6% inci-
dence in their series with an inclusion tech-
nique retaining 1 or more sinuses is indeed
concerning. We concur that meticulous at-
tention to closure of the dead space between
the native and implanted sinus walls is crit-
ical. When we were using the ‘‘scallop’’
technique, we did use obliterating sutures,
which clearly did not obviate this single oc-
currence. We can only speculate about the
potential usefulness of biologic glues to en-
hance fusion of the walls. In contrast to their
100% reoperation rate, our single case
report was also written to make the point
that in the absence of valve dysfunction,
progressive dehiscence, or the development
of thrombus, conservative management
appears to be safe with antiplatelet therapy
and consistent yearly imaging follow-up.
Richard A. Hopkins, MD
Department of Cardiac Surgery
Children’s Mercy Hospital
Kansas City, Mo
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The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commentary
on an article published in the Journal or
other relevant issues. Authors should:
 Include no more than 500 words of
text, three authors, and five refer-
ences
 Type with double-spacing
 See http://jtcs.ctsnetjournals.org/
misc/ifora.shtml for detailed sub-
mission instructions.
 Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will
be given an opportunity of offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
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EditorManagement of postintubation
tracheal ruptures
To the Editor:
We read with interest the article by Park and
colleagues,1 who described a new approach
for the intraluminal repair of membranous
tracheal rupture (TR) after emergency intu-
bation. We congratulate them for their result
in an elderly patient in poor condition.
The authors discussed the value of the
different approaches to surgical treatmentlar Surgery c Volume 136, Number 1 231
Reply to the Editor:
We thank Dr. Conti and associates for their
comments on our report.1 We agree that
conservative management could be the
best method for the treatment of postintuba-
tion tracheal rupture (TR), especially in sta-
ble and spontaneously ventilating patients.
However, we disagree with their remark
that surgical treatment results in a higher
mortality rate than conservative or mechan-
ical ventilation in TR. According to reports
about experience with surgical treatment
based on relatively large series of pa-
tients,2-4 there were no operation-related
deaths or complications after surgical treat-
ment for TR. The cause of death in TR
was not the surgical treatment but the under-
lying condition that necessitated intubation.
Surgical treatment was also safe for patients
in stable condition.
In general, conservative treatment is se-
lected for first-line treatment. However, we
cannot conclude that conservative treatment
can succeed in all patients on the basis of ex-
perience from this small series of patients.5
If conservative management fails, subsequent
surgical treatment would be more compli-
cated and the chance of mortality would in-
crease. Mechanical ventilation (MV) with
bridging or selective ventilation also could
be applied in patients unfit for conservative
care. However, MV needs complicated
management and intensive care, which
could induce unforeseen complications.
MV requires more medical facilities, cost,
and time. Treatment failure with MV is
also fatal. Of 14 patients treated by MV in
the report by Conti and associates,5 1 patient
died suddenly on day 3 after an episode of
acute hypoxemia, which might be a compli-
cation of TR, and 2 patients could not sur-
vive despite delayed surgical treatment.
Surgical treatment has some advantages
over conservative treatment or MV. It is de-
finitive and safe treatment. The success rate
is also high. The duration of treatment is
relatively short. A weak point is the inva-
siveness. However, this could be minimized
with various less invasive approach
methods such as our method. It is apparent
that conservative treatment can be the first
choice in patients who are in stable condi-
tion and breathing spontaneously after TR
according to the experience of recent litera-
ture and Conti’s work. However, physicians
should be able to select the best method and
offer tailored treatment for each patient on
the basis of clear knowledge about advan-
tages and disadvantages of each treatment
modality because TR mostly develops in
complicated situation and the failure of the
treatment might be fatal. The patient in our
report1 was not suitable for conservative
treatment because she was not in stable con-
dition and spontaneous ventilation seemed
impossible. We thought that more definitive
treatment and a shorter duration of treatment
would be better for this elderly patient in
poor condition. We already had enough
experience with tracheal surgery and confi-
dence about surgical outcome. We selected
to use surgical treatment as the treatment
of choice.
In Kyu Park, MD
Department of Thoracic and
Cardiovascular Surgery
Yonsei University College of Medicine
Seoul, Republic of Korea
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Letters to the Editorof TR, mainly transtracheal endoluminal
repair through different-shaped anterior tra-
cheotomies. They consider the endoluminal
approach ‘‘technically complicated owing
to limited accessibility and needs a rela-
tively long tracheal injury and complex
ventilation management.’’ We agree with
this opinion even though semilateral trans-
verse tracheotomy allows better repair in
this field.
However, conservative treatment was
not discussed, and we consider that the pa-
tient could have been managed as follows:
prompt placement of a tube in the left side
of the chest, microdrainage of subcutaneous
emphysema, and advancement of the endo-
tracheal tube distal to the TR to ensure
bridging the lesion and mechanical ventila-
tion, which was required to treat the under-
lying conditions (atelectasis, delirium).
According to the evidence accumulated
in the recent literature and our own experi-
ence,2-5 surgical treatment of postintubation
TR leads to higher mortality than does con-
servative management. In patients managed
surgically, the initial indication for which
the patient was intubated plays a crucial
role in postoperative mortality: among pa-
tients who underwent emergency intubation
for an acute medical event, surgery is usu-
ally a high-risk procedure4 as compared
with conservative management (mortality
rate 47% vs 29%).5 Such a high mortality
for the repair of TR demands that alterna-
tives to high-risk surgery be considered
and surgical repair be reserved for patients
in whom bridging the lesion is technically
not feasible or for patients with TR
diagnosed during thoracic surgery.
Alain Wurtz, MD
Lotfi Benhamed, MD
Massimo Conti, MD
Henri Porte, MD, PhD
Chirurgie Thoracique
Hopital Calmette
CHU Lille
Lille, France
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